News

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...
A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers ...
Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread ...
A new research paper was published in Aging (Aging-US) Volume 17, Issue 3, on March 12, 2025, titled "DNA methylation entropy is a biomarker for aging." ...
Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer ...
Interleukin-6 could help physicians diagnose sepsis early in children and pregnant women, according to a real-world study presented at the ESCMID Global meeting 2025.“Traditional biomarkers have a lag ...
A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers ...
The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...
Nine of the grocer’s stores in Maryland and Virginia will offer a new blood test that screens for multiple cancer types and ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Individuals with a genetic predisposition to Alzheimer’s disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.
Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...